Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19377 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:17 UTC
19377
Studies in scope
all four open statuses
11904
Recruiting now
open to new participants
2037
Lead sponsors
across recruiting studies
Top sites
Beijing 14 Shanghai 13 Wuhan 12 Nanjing 6 Chengdu 6

Trials with a site in Beijing

14 of 19377 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Phase 1 Clinical Study of GenSci164 Injection
NCT07790783Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
56
Beijing
2026-08-24
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
42
Beijing, Xinxiang, Nanjing, Nanchang, Changchun, Jinan, Taiyuan, Tianjin
2026-08-15
Not yet open
Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults
NCT07638800Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
68
Beijing
2026-07-28
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Observational
200
Beijing
2026-04-30
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
186
Beijing
2026-04-01
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
382
Beijing
2025-09-12
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
64
Beijing
2025-06-09
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
200
Beijing
2025-05-26
Not yet open
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
60
Hefei, Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Nanjing, Nanchang
2024-09-20
Recruiting
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
NCT06189495Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
30
Beijing, Wuhan, Jinan, Chengdu
2023-12-30
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicable
290
Beijing, Chongqing, Changsha, Nanjing, Suzhou, Shanghai, Xi’an, Chengdu
2023-12-01
Active, closed
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
360
Beijing, Wuhan, Changsha, Naning, Nanjing, Wuxi, Nanchang, Changchun
2017-05-12
Active, closed
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
NCT02375620Short Stature Children Born Small for Gestational Age (SGA)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
96
Beijing, Wuhan, Changsha, Wuxi, Nanchang, Changchun, Shanghai, Taiyuan
2015-04-23
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,377 studies in total at the last sync on 19 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

9 of the 14 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 14 studies
PhaseStudiesRecruitingShare
Phase 15335.7%
Phase 25335.7%
Phase 32114.3%
Not applicable117.1%
Observational117.1%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Changchun GeneScience Pharmaceutical Co., Ltd.149
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.